Polyfluoreno[4,5-cde]oxepine polymers and conjugates thereof

US9896538B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9896538-B2
Application numberUS-201715469952-A
CountryUS
Kind codeB2
Filing dateMar 27, 2017
Priority dateMar 28, 2016
Publication dateFeb 20, 2018
Grant dateFeb 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides for polyfluoreno[4,5-cde]oxepine conjugates and their use in methods of analyte detection.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymer comprising monomers of formula A wherein X is the number of monomer A units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein X is from 6 to 100; and one or more monomers selected from the group consisting of monomer of formula B wherein Y is the number of monomer B units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein Y is from 0 to 99; and monomer of formula C wherein Z is the number of monomer C units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein Z is from 0 to 99; wherein R1 to R6 independently is hydrogen, an alkyl, a polyethyleneglycol (PEG), an aryl, a heteroaryl group, or a biological substrate conjugated via a linker (L-BS); wherein SG1 to SG6 independently is an alkyl, a water soluble group or a L-BS; and wherein the polymer includes end groups HG1 and HG2 wherein HG1 and HG2 independently is a hydrogen, an alkyl, a halogen, a boronyl, an aryl, a heteroaryl group or a L-BS; wherein the ratio of X to Y+Z is >1, wherein the sum of X+Y+Z is >10. 2. The polymer of claim 1 , wherein the polymer comprises an L-BS and the ratio of BS to polymer is 0.2-3. 3. The polymer of claim 1 wherein monomer unit B and monomer unit C are different. 4. The polymer of claim 1 , wherein the monomer units are directly connected to one another. 5. The polymer of claim 1 , wherein the linker comprises an alkyl, a PEG, a carboxamide, a thioether, an ester, an imine, a hydrazine, an oxime, an alkyl amine, an ether, an aryl amine, a boronate ester, an N-acylurea or anhydride, a platinum complex, an aminotriazine, a triazinyl ether, an amidine, a urea, a urethane, a thiourea, a phosphite ester, a silyl ether, a sulfonamides, a sulfonate ester, a 1,2,3-triazole, a pyradazine, a thiazolidine, a 2-diphenylphosphonyl-benzoamide, an isoxazole or a succinimide group. 6. The polymer according to claim 1 , wherein: (i) R1 to R6 independently represent hydrogen, methyl, or ethyl; and/or (ii) SG1 to SG6 independently represent a PEG, an alkyl, a carboxyalkyl, a sulfonylalkyl, a phosphonylalkyl, an aminoalkyl or L-BS; and/or (iii) L is an alkyl chain or a PEG chain; and/or (iv) BS is an antibody, a peptide, a protein, an oligonucleotide, a nucleic acid or a carbohydrate; and/or (v) HG1 and HG2 independently represent a hydrogen, an aryl, a halogen or a boronyl; and/or (vi) x is an integer from 11-80 and y and z are each an integer independently selected from 0-80, provided that (1) the ratio of BS/polymer is 1-2, (2) the ratio of x/(y+z) is >1, and (3) the sum of x+y+z is >20. 7. The polymer according to claim 1 , wherein: (i) R1 to R6 are hydrogen; and/or (ii) SG1 and SG2 are PEG; and/or (iii) SG3 to SG6 independently represent a PEG, an alkyl, a carboxyalkyl, a sulfonylalkyl, a phosphonylalkyl, an aminoalkyl or a L-BS. 8. The polymer according to claim 1 , wherein: (i) SG3 to SG6 independently represent a PEG, an alkyl, a carboxyalkyl, or a L-BS; or (ii) SG3 to SG6 independently represent a PEG, an alkyl, an aminoalkyl or a L-BS. 9. The polymer of claim 8 , wherein alkyl is a methyl group. 10. The polymer of claim 1 , wherein R1 to R6 are hydrogen; wherein SG1 to SG6 independently represent a PEG, an alkyl, a carboxyalkyl, a sulfonylalkyl, a phosphonylalkyl, or an aminoalkyl; wherein HG1 and HG2 independently represent a hydrogen, an aryl, a halogen, a boronyl or a L-BS; wherein L comprises an alkyl chain or a PEG chain; wherein BS is an antibody, a peptide, a protein, an oligonucleotide, a nucleic acid or a carbohydrate; and wherein x is an integer from 16-80 and y and z are each an integer independently selected from 0-80, provided that (1) the ratio of BS/polymer is 1-2, (2) the ratio of x/(y+z) is >1, and (3) the sum of x+y+z is >20. 11. The polymer according to claim 1 , wherein SG1 and SG2 are independently PEG6 to PEG18. 12. The polymer according to claim 1 , wherein the ratio of BS/polymer is 1; x is an integer from 16-80, y and z are each an integer independently selected from 0-64 and wherein the sum of x+y+z is 30-80. 13. The polymer according to claim 1 , wherein: (i) HG1 and HG2 independently represent a hydrogen, a carboxyaryl, or a L-BS; or (ii) HG1 and HG2 independently represent a halogen, a boronyl, a carboxyaryl, or a L-BS. 14. A polymer comprising monomers of formula D wherein W is the number of monomer D units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein W is from 6 to 100; and one or more monomers selected from the group consisting of monomer of formula E wherein X is the number of monomer E units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein X is from 0 to 98; monomer of formula F wherein Y is the number of monomer F units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein Y is from 1 to 20; and monomer of formula G wherein Z is the number of monomer G units in the polymer wherein the monomer units are consecutive or nonconsecutive and wherein Z is from 0 to 98; and wherein R1 to R6 independently is hydrogen, an alkyl, a polyethyleneglycol (PEG), an aryl, a heteroaryl group, or a biological substrate conjugated via a linker (L-BS); wherein SG1 to SG7 independently is an alkyl, a water soluble group or a L-BS; and wherein the polymer includes end groups HG1 and HG2 wherein HG1 and HG2 independently is a hydrogen, an alkyl, a halogen, a boronyl, an aryl, a heteroaryl group or a L-BS; wherein the ratio of W to X+Y+Z is >1, wherein the sum of W+X+Y+Z is >10, wherein FP is a fluorophore or fluorescent dye that has absorption maximum longer than 450 nm and emission maximum longer than 500 nm with fluorescence quantum yield greater than 5%. 15. The polymer of claim 14 , wherein the polymer comprises an L-BS and the ratio of BS to polymer is 0.2-3. 16. The polymer of claim 14 wherein monomer unit E and monomer unit G are different. 17. The polymer according to claim 14 , wherein the monomer units are directly connected to one another. 18. The polymer according to claim 14 , wherein the linker comprises an alkyl, a PEG, an FP, a carboxamide, a thioether, an ester, an imine, a hydrazine, an oxime, an alkyl amine, an ether, an aryl amine, a boronate ester, an N-acylurea or anhydride, a platinum complex, an aminotriazine, a triazinyl ether, an amidine, a urea, a urethane, a thiourea, a phosphite ester, a silyl ether, a sulfonamides, a sulfonate ester, a 1,2,3-triazole, a pyradazine, a thiazolidine, a 2-diphenylphosphonyl-benzoamide, an isoxazole or a succinimide

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9896538B2 cover?
The invention provides for polyfluoreno[4,5-cde]oxepine conjugates and their use in methods of analyte detection.
Who is the assignee on this patent?
Aat Bioquest Inc, Affymetrix Inc
What technology area does this patent fall under?
Primary CPC classification C08G61/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).